Načítá se...
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth
BACKGROUND: Arsenic compounds have modest cytotoxic activity in solid tumors. We investigated if arsenic sulfide (As(4)S(4)) in combination with other distinct agents could enhance its cytotoxic activity. METHODS: We used gastric and colon cancer cell lines to study the synergistic effect of As(4)S(...
Uloženo v:
| Vydáno v: | Drug Des Devel Ther |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634829/ https://ncbi.nlm.nih.gov/pubmed/26586936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92943 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|